History

Seegene's History

2017Year

  • 2017.12
    • Expand logistics facilities for MDx products
  • 2017.11
    • Establish a subsidiary - Seegene Germany GmbH - in Germany
  • 2017.09
    • MOU with Hamilton for co-developing
  • 2017.06
    • MOU with Mexico Government Agriculture Agency for
      Collaborative Development of Non-human MDx Assay
  • 2017.05
    • Collaboration with Thermo Fisher for FDA clearance of
      the MDx assays and instruments
  • 2017.04
    • Patent Seegene’s new generation of real-time technology (TOCE™)
      in the leading countries including the United States
  • 2017.02
    • Develop New Normalization Software Technology for molecular diagnosis
  • 2017.01
    • Present ‘All MDx Assays in One Platform’ solution
      at the 34th Annual J.P. Morgan Healthcare Conference

2016Year

  • 2016.12
    • Head of the Seegene Middle East, awarded the Minister’s Award of Trade,
      Industry and Energy of Korea
  • 2016.11
    • Signed collaboration agreement with Hologic for
      developing high multiplex molecular diagnostic assays
    • Signed MOU with Institut Català d'Oncologia(ICO) in
      Spain for mutual cooperation
  • 2016.10
    • Expansion of production facilities
  • 2016.09
    • Acquired Neoprobe for better custom oligo synthesis service
    • Launched SG Oligo designing service
    • President of Seegene Middle East, awarded a commendation from
      minister of Ministry of trade, industry and energy for ‘Merit in Exportation’
  • 2016.07
    • Signed MOU with DGIST for mutual cooperation
  • 2016.06
    • Launched SG Oligo designing system
    • Awarded In-Vitro Diagnostics Company of the Year at
      the 2016 Frost & Sullivan South Korea Excellence Awards
  • 2016.05
    • Launched RUO products (Novaplex™) for U.S. market
    • Developed STARMag 96 X 4 Universal Cartridge Kit for
      nucleic acid extraction of multiple specimen types
  • 2016.04
    • Establishing a joint venture with Biodist Group in
      Mexico: Biodist-Seegene Diagnostics

2015Year

  • 2015.09
    • Signed the ODM supply agreement with BD(Becton, Dickinson)
    • Awarded the 2015 South Korea In-Vitro Diagnostics Company of the Year
  • 2015.07
    • Signed CDx collaboration agreement with QIAGEN
    • Established CANADA subsidiary
  • 2015.06
    • Established USA subsidiary
  • 2015.02
    • Receives FDA Clearance for its HSV Molecular Test

2014Year

  • 2014.12
    • Selected as the ‘World class product of KOREA’ (Respiratory virus detection kit,
      STI pathogen detection kit)
  • 2014.11
    • Signed the first global ODM supply agreement with Beckman Coulter Diagnostics
      (Danaher)
  • 2014.10
    • Established subsidiaries - Seegene Middle East, in Dubai
  • 2014.07
    • Licensed TOCE™ to Eisai(Japan) for companion diagnostics(CDx)
    • Developed MuDT™ (Simultaneous quantification and detection of multiple
      targets in a single fluorescence channel)
  • 2014.04
    • Listed on KOSDAQ’s Hidden Champion for fourth consecutive year
  • 2014.01
    • Established subsidiaries in Italy

2013Year

  • 2013.09
    • Awarded the 4th Vivid KOSDAQ Award
      (Trade, Industry, and Energy Minister Award)
      (sponsored by The Herald Biz)
  • 2013.06
    • Awarded the Korean Ethical Business Award for five consecutive years
      (sponsored by the Korea Economy Magazine)
    • Selected as the Best Bio Company in the "Korea's Best Company Awards"
      for two consecutive years (sponsored by the Korean CEO Association, KCEOA)
  • 2013.05
    • Selected as 'KOSDAQ Hidden Champion' three consecutive years
      (Korea Stock Exchange(KRX))
  • 2013.04
    • Technology transfer Agreement in food safety inspection field with Biomeriux
  • 2013.03
    • United Global Healthcare partnership agreement with Neodin Medical Institution.
    • Supply agreement with Europe Screening Center Synlab Holding GmbH Group.
  • 2013.01
    • Partnership with SK Telecom to expand molecular diagnostics business.
    • Recruitment of US Focus Diagnostics CEO as a B2B Executive Vice president.

2012Year

  • 2012.10
    • CEO of Seegene Receives Gold Award in Best CEO of the Year at International
      Business Awards
  • 2012.09
    • Awarded 2012 Korea Ethics Management Award(Korean Economic Magazine)
  • 2012.07
    • TOCE™ Technology Introduction at the AACC Conference:
      TOCE™ Technology Paper presentation (Seegene Bulletin)
  • 2012.06
    • 2012 Korea's Best Company Awards' "Small Giants" Award
      (Supervised by Korean Chief Executive Officers Association)
    • Seegene Selected as 'KOSDAQ Hidden Champion' for two Consecutive Years.
  • 2012.05
    • Seegene Signs Product Development Agreement with DuPont (US)
  • 2012.01
    • Acquired Medical Device manufacturing reagents for gene amplification.

2011Year

  • 2011.11
    • Awarded the Innovative Entrepreneur Award at the 2011 Start-up Awards
      (sponsored by the Korean Society of Business Venturing)
  • 2011.10
    • Awarded ‘Excellence award in KOSDAQ division’ from the 11th Korea IR awards.
      (sponsored by Korea Exchange and Korea IR Services
  • 2011.08
    • U.S. Subsidiary relocation and expansion
  • 2011.07
    • Awarded 2011 Korea Ethics Management Award (Korean Economic Magazine)
  • 2011.05
    • Awarded 2011 Hidden Champion (Korea Stock Exchange)
    • Non-exclusive technology transfer contracting with United States'
      Akonni Biosystems
  • 2011.04
    • KGMP appropriate certification(Manufacturing license)
      - Electric Testing Institute CE Marking
  • 2011.03
    • contract for sepsis causing pathogen detection kits with Germany's Molzym
  • 2011.01
    • Seegene and Caliper strategic partnership to Provide Innovative
      Multiplex Molecular Diagnostics Products.
    • Awarded 2010 Asia Pacific Frost & Sullivan Technology Innovation Award in
      Multiplexed Real-time PCR.

2010Year

  • 2010.11
    • Five Million Dollar Export Tower (KITA)
    • Innovation leaders led South Korea to 2010 (Newsmaker)
    • Established Seegene Germany in Eschborn, Germany.
  • 2010.10
    • 2010 Korea Ethical Management Award (Hankyung Magazine)
    • Iron Tower Order of Industrial Venture Company Award (KOVA)
  • 2010.09
    • Phase II Small Business Innovation President
      (SMBA, INNOBIZ, KAIARI, KOSHBA, TIPA, KIBO, BCF)
    • Initial Public Offering on the KOSDAQ
  • 2010.08
    • Geulrobeolrideosang Awards 2010 (KSME, Hankyung)
  • 2010.07
    • 2010 Korea Health Industry Award
      (Health Industry CEO Summit)
  • 2010.05
    • IR52 Jang Young Shil Award
      (KOITA, MK Business News)
  • 2010.04
    • Hidden Champion (Innobiz, Joong Ang Daily )
  • 2010.03
    • 2010 Korea Best CEO Awards (Hankyung Magazine)
  • 2010.02
    • 2010 Korea Ethics Management Award (Korea Times)

2009Year

  • 2009.12
    • 2009 Best CEO leading Korea's economy (Hankyung Magazine)
    • 2009 World Class Product of Korea (MKE)
    • 2009 Health Industry Technology award (MW, KHIDI)
    • Obtained ISO 9001:2008 Certification (BSI, British Standards Institution)
  • 2009.11
    • Prize of High Performance Award (KITA)
  • 2009.10
    • 2009 Korea Ethics Management Award (Hankyung Business)
  • 2009.09
    • 2009 Korea New Growth Engine Award
      (Digital Chosun Ilbo)
  • 2009.08
    • 2009 Korea Health Industry (Health Industry CEO Summit)
    • Completed the US Patent Registration of ACP™ Technology
    • Achieved an Israeli Patent for ACP™ Technology
  • 2009.04
    • DPO™ Technology approved for HT Certification by the Ministry of
      Health and Welfare of Korea
    • Selected as one of the world's top 30 companies manufacturing molecular
      diagnostic products for infections(Research and Markets)
  • 2009.03
    • Contracted non-exclusive licenseing agreement with Randox Laboratories for
      DPO™ technology
  • 2009.02
    • Received Japan patent for ACP™ Technology
  • 2009.01
    • Registered Nucleotide Variation Detection Technology for a Korean Patent

2008Year

  • 2008.12
    • Exporting Company with Great Potential Award (SMBA)
    • Received Republic of South Africa patent for DPO ™ Technology
  • 2008.11
    • Awarded a Medicine Innovation Award (Frost & Sullivan)
  • 2008.10
    • Obtained Canadian Medical Devices Conformity Assessement System
      (CMDCAS)Certification
  • 2008.09
    • Received European Patent for ACP ™ Technology
    • Registered STD Pathogens Detection Technology for a Korean Patent
  • 2008.07
    • Received Singapore Patent for DPO ™ Technology
  • 2008.06
    • Partnership between Seegene and Lab901 to develop automated molecular
      diagnostic system
  • 2008.05
    • Registered a Medical Devices Import License
  • 2008.03
    • Registered CP™ Technology for an Indian Patent
    • Received Korean patent for DNA Walking Technology
  • 2008.01
    • Digital Innovation Award (Prize of Minister)

2007Year

  • 2007.12
    • Awarded Government Awards for the Commercialization of New
      Technology (Trade, Industry, and Energy Minister Award)
  • 2007.11
    • Re-designated with Venture Company Certification
      (KOTEC, Korea Technology Finance Corporation)
  • 2007.10
    • Established Seegene Japan in Tokyo in Japan
    • Obtained ISO13485 Certification (No.: MD 525027)
  • 2007.05
    • Obtained ISO9001:2000 Certification (No.: JK-12502)
    • Received New Zealand patent for ACP ™ Technology
  • 2007.03
    • Selected as an InnoBiz Company
      (SMBA, Small and Medium Business Administration)
  • 2007.02
    • Presented a DPO™ Technology paper (Nucleic Acid Research)

2004Year

  • 2004.11
    • Launching the GeneFishing™ DEG discovery service
  • 2004.09
    • Relocated Seegene US office in Maryland, USA
  • 2004.03
    • Renamed and renewed Seegene webpage in English(www.seegene.com)
      Opened Seegene webpage in Korea (www.seegene.co.kr)
  • 2004.01
    • Contracted a licensing agreement with Sigma-Aldrich, US for
      GeneFishingTM Technology

2003Year

  • 2003.11
    • Re-designated as a Venture Company (Seoul SMBA)

2002Year

  • 2002.11
    • Established Seegene USA in San Diego, USA.
      Launched GeneFishingTM Kit

2001Year

  • 2001.12
    • Selected as a high technology and company by Korea Technology
      Credit Guarantee Fund
  • 2001.11
    • Acknowledged as a 'Venture Company' by Seoul SME Association
  • 2001.03
    • Relocated Headquarters to Samsung-dong, Seoul, Korea
  • 2001.01
    • Opened Seegene webpage (www.see-gene.com)

2000Year

  • 2000.11
    • Designated as an Excellent Venture Company for Technology
      Evaluation(Seoul SMBA)
  • 2000.09
    • Established Seegene, Inc. and Institute of Life science
      at Ehwa Women's University, Seoul, Korea
home > Introduction > History